A Study to Evaluate Chlorhexidine Wipes to Reduce Surgical Site Infection Risk in Spine Surgery Patients

Overview

About this study

The purpose of this study is to determine the optimal length of use in days of the chlorhexidine gluconate wipes compared to standard wound care in the post-operative spinal patient discharge wound care.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult 18+ years.
  • Post-operative spine patients being discharged within three post-operative days.
  • English speaking.

Exclusion Criteria: 

  • Pediatric patients 17 and younger.
  • Non-English speaking patients.
  • Allergy to chlorhexidine.
  • Allergy to commercially bottled soap.
  • Any chronic skin sensitivity issues.
  • Outpatient post-operative spine patients.
  • Post-operative spine patients admitted beyond POD 3.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Christine Aliory, APRN, D.N.P., R.N.

Open for enrollment

Contact information:

Christine Aliory APRN, D.N.P., R.N.

(480) 342-0343

Aliory.Christine8@mayo.edu

More information

Publications

Publications are currently not available